Literature DB >> 7533125

Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous human antibodies.

G Ballardini1, P Groff, F Giostra, R Francesconi, R Miniero, S Ghetti, D Zauli, F B Bianchi.   

Abstract

Hepatitis C virus (HCV) antigens in liver biopsy have been detected by immunohistochemistry using both spontaneous human IgG and murine monoclonal or rabbit polyclonal monospecific reagents. Conflicting results have been obtained in different studies. This was probably because of the incapacity of single experimental antibodies, raised against synthetic or recombinant peptides, to recognize native tissue antigens. To overcome this possibility, we immunopurified monospecific spontaneous polyclonal human Ig, therefore induced by native antigens, from the single antigen-containing bands of RIBA 3 strips. Antibodies to c100, c33, c22, and NS5 antigens were obtained from the serum of a patient affected by chronic hepatitis C. The IgG fraction of this serum had proved to stain tissue HCV antigens. Eight biopsies were selected on the basis of strong hepatocellular reactivity with the whole IgG fraction in a variable number (from 5% to 75%) of cells. The four antigens were detected in all biopsies; a clear cellular codistribution was observed on serial sections. These data demonstrate that the possibility to identify HCV antigens in liver biopsies is higher when using human antibodies induced by native antigens rather than experimental antibodies. The approach of immunopurification of human antibodies can be extended to other HCV-related epitopes to obtain reagents useful for the selection and optimization of monoclonal or polyclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533125

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

Review 1.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

2.  HCV NS3Ag: a reliable and clinically useful predictor of antiviral outcomes in genotype 1b hepatitis C virus-infected patients.

Authors:  S Ren; Y Jin; Y Huang; L Ma; Y Liu; C Meng; S Guan; L Xie; X Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-13       Impact factor: 3.267

3.  Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression.

Authors:  Bozena Walewska-Zielecka; Kazimierz Madalinski; Joanna Jablonska; Paulina Godzik; Joanna Cielecka-Kuszyk; Bogumila Litwinska
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

4.  Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.

Authors:  Mariarosa Tamè; Federica Buonfiglioli; Massimo Del Gaudio; Andrea Lisotti; Paolo Cecinato; Antonio Colecchia; Francesco Azzaroli; Antonietta D'Errico; Rosario Arena; Claudio Calvanese; Chiara Quarneti; Giorgio Ballardini; Antonio Daniele Pinna; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

5.  Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation.

Authors:  F Fenwick; M F Bassendine; K Agarwal; D Bevitt; W Pumeechockchai; A D Burt; G L Toms
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

6.  Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.

Authors:  Marie-Laure Plissonnier; Thomas Lahlali; Maud Michelet; Fanny Lebossé; Jessica Cottarel; Melanie Beer; Grégory Neveu; David Durantel; Birke Bartosch; Rosita Accardi; Sophie Clément; Andrea Paradisi; Mojgan Devouassoux-Shisheboran; Shirit Einav; Patrick Mehlen; Fabien Zoulim; Romain Parent
Journal:  PLoS Biol       Date:  2016-03-31       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.